What is abatacept (Enrisu) and its main clinical effects and indications?

Abatacept is an immunomodulatory biological agent that is a selective co-stimulation modulator (Selective Co-stimulation Modulator). It mainly works by regulating the activation of T cells. Its molecular mechanism is to bind to the CD28 receptor costimulatory signal on the surface of T cells, thereby inhibiting the activation and proliferation of T cells and indirectly reducing the inflammatory response. Compared with traditional immunosuppressants, abatacept can more specifically regulate immune system activity and reduce systemic side effects. It is one of the more advanced biological drug options in the treatment of rheumatic immune diseases.

In clinical application, abatacept is mainly used to treat moderately to severely active rheumatoid arthritis (RA), especially for patients who have poor response to methotrexate or other conventional anti-rheumatic drugs. By inhibiting the inflammatory response mediated by TT cells, abatacept can reduce joint pain and swelling, delay joint structural destruction, and improve patients' joint function and quality of life. In addition, it is also used to treat juvenile idiopathic arthritis (JIA) and certain refractory rheumatic diseases, providing these patients with an effective treatment option.

In terms of efficacy, multiple clinical studies have shown that abatacept can significantly improve the clinical symptoms and imaging indicators of patients with rheumatoid arthritis. Patients treated with abatacept had a significant decrease in disease activity score (DAS28), relief of joint inflammation and pain, and were able to delay the bone destruction process shown by the X line. For patients who have not been adequately controlled by long-term use of traditional drugs, abatacept provides a new treatment strategy, making it widely recognized in clinical practice.

It should be noted that abatacept is a biological agent, and attention should be paid to the risk of infection and potential immunosuppressive effects when using it. Patients need to undergo tuberculosis, hepatitis B and other related screening before treatment, and blood routine and liver and kidney functions need to be monitored regularly during treatment. In addition, because the price of this drug is relatively high and it is not included in medical insurance in some areas, patients need to develop an individualized treatment plan based on their financial affordability and the recommendations of clinicians when using it. Overall, abatacept, as a precision immunomodulatory drug, plays an important role in the treatment of rheumatoid arthritis and other rheumatic immune diseases, providing patients with a safe and effective treatment option.

Reference materials:https://www.drugs.com/